[Pathogenesis of hypolipidemia].
Teramoto
T
T
Department of Internal Medicine, Teikyo University School of Medicine.
D000924:Anticholesteremic Agents / Q000009:adverse effects; D016632:Apolipoprotein A-I / Q000172:deficiency / Q000235:genetics; D001796:Blood Protein Disorders / Q000150:complications / Q000378:metabolism; D006402:Hematologic Diseases / Q000150:complications / Q000378:metabolism; D006801:Humans; D006995:Hypobetalipoproteinemias / Q000145:classification / Q000209:etiology; D007009:Hypolipoproteinemias / Q000145:classification / Q000209:etiology; D050356:Lipid Metabolism; D008107:Liver Diseases / Q000150:complications / Q000378:metabolism; D008222:Lymphokines / Q000009:adverse effects; D009154:Mutation; D009369:Neoplasms / Q000150:complications / Q000378:metabolism; D011341:Probucol / Q000009:adverse effects; D013631:Tangier Disease; D013959:Thyroid Diseases / Q000150:complications / Q000378:metabolism
D000924:Anticholesteremic Agents; D016632:Apolipoprotein A-I; D008222:Lymphokines; D011341:Probucol